Azacitidine is a medication used to treat certain types of blood cancers, including myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). It works by slowing or stopping the growth of cancer cells.
The typical recommended dose of Azacitidine injection is 75 mg/m Square/day given subcutaneously (under the skin) or intravenously (into a vein) for 7 days, followed by a 21-day rest period. The dosage and treatment schedule may vary depending on the individual patient's medical condition and response to the medication.
The injection is usually administered by a healthcare professional in a clinical setting. Patients may be monitored for a period of time after the injection to monitor for any adverse reactions.
Common side effects of Azacitidine may include nausea, vomiting, fatigue, and decreased appetite. More serious side effects may include low blood cell counts, increased risk of infection, and allergic reactions. If you experience any concerning symptoms or side effects, be sure to speak with your doctor as soon as possible.